Congenital disorders of glycosylation

Gene: LFNG

Green List (high evidence)

LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)
EnsemblGeneIds (GRCh38): ENSG00000106003
EnsemblGeneIds (GRCh37): ENSG00000106003
OMIM: 602576, Gene2Phenotype
LFNG is in 9 panels

4 reviews

Arina Puzriakova (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to Green and the mode of inheritance set to BIALLELIC, autosomal or pseudoautosomal following NHS Genomic Medicine Service approval.
Created: 24 Feb 2025, 5:41 p.m. | Last Modified: 24 Feb 2025, 5:41 p.m.
Panel Version: 6.10

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Achchuthan Shanmugasundram (Genomics England Curator)

Green List (high evidence)

Comment on list classification: There is sufficient evidence available for the promotion of this gene to green rating in the next GMS update.
Created: 5 Oct 2024, 8:54 p.m. | Last Modified: 5 Oct 2024, 8:54 p.m.
Panel Version: 6.4
LFNG encodes a fucose-specific beta-1,3-N-acetylglucosaminyltransferase that modifies Notch receptors and alters Notch signaling activity.

There are more than 10 unrelated cases reported with Spondylocostal dysostosis and with biallelic LFNG variants (either homozygous or compound heterozygous).

This gene has been associated with relevant phenotypes in both OMIM (MIM #609813) and Gene2Phenotype (with 'definitive' rating on DD and Skeletal panels).
Created: 5 Oct 2024, 8:50 p.m. | Last Modified: 5 Oct 2024, 8:50 p.m.
Panel Version: 6.1

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Spondylocostal dysostosis 3, autosomal recessive, OMIM:609813

Publications

Sarah Leigh (Genomics England Curator)

Comment when marking as ready: Associated with phenotype in OMIM and as a confirmed Developmental Disorder Gene / G2P. Only one variants reported.
Created: 19 Dec 2016, 10:18 a.m.

Daniel Ungar (University of York, Department of Biology)

Red List (low evidence)

Single known patient with Spondylocostal Dysostosis. Biochemical function of the gene and the described mutation are consistent with inclusion of this gene on the list, and other patients could be present.
Created: 13 Dec 2016, 11:16 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • Expert Review Green
  • UKGTN
  • Radboud University Medical Center, Nijmegen
  • Literature
  • Emory Genetics Laboratory
Phenotypes
  • Spondylocostal dysostosis 3, autosomal recessive, OMIM:609813
  • O-fucose-specific beta-1,3-N-acetylglucosaminyltransferase deficiency (Disorders of protein O-glycosylation, O-mannosylglycan synthesis deficiencies)
OMIM
602576
Clinvar variants
Variants in LFNG
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

24 Feb 2025, Gel status: 3

Removed Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_24_promote_green was removed from gene: LFNG.

24 Feb 2025, Gel status: 3

Added New Source, Added New Source, Status Update

Arina Puzriakova (Genomics England Curator)

Source Expert Review Green was added to LFNG. Source NHS GMS was added to LFNG. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

5 Oct 2024, Gel status: 2

Added Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q3_24_promote_green tag was added to gene: LFNG.

5 Oct 2024, Gel status: 2

Entity classified by Genomics England curator

Achchuthan Shanmugasundram (Genomics England Curator)

Gene: lfng has been classified as Amber List (Moderate Evidence).

5 Oct 2024, Gel status: 1

Set Phenotypes

Achchuthan Shanmugasundram (Genomics England Curator)

Phenotypes for gene: LFNG were changed from ?Spondylocostal dysostosis 3, autosomal recessive 609813; O-fucose-specific beta-1,3-N-acetylglucosaminyltransferase deficiency (Disorders of protein O-glycosylation, O-mannosylglycan synthesis deficiencies) to Spondylocostal dysostosis 3, autosomal recessive, OMIM:609813; O-fucose-specific beta-1,3-N-acetylglucosaminyltransferase deficiency (Disorders of protein O-glycosylation, O-mannosylglycan synthesis deficiencies)

5 Oct 2024, Gel status: 1

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: LFNG were set to 16385447

19 Dec 2016, Gel status: 1

panel promoted to version 1

Sarah Leigh (Genomics England Curator)

Promoted to V1 19th December 2016

19 Dec 2016, Gel status: 1

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

19 Dec 2016, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for LFNG were set to 16385447

19 Dec 2016, Gel status: 1

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

1 Dec 2016, Gel status: 3

Added New Source

Sarah Leigh (Genomics England Curator)

LFNG was added to Congenital disorders of glycosylationpanel. Source: UKGTN

1 Dec 2016, Gel status: 2

Added New Source

Sarah Leigh (Genomics England Curator)

LFNG was added to Congenital disorders of glycosylationpanel. Source: Radboud University Medical Center, Nijmegen

1 Dec 2016, Gel status: 1

Set Mode of Inheritance, Added New Source

Sarah Leigh (Genomics England Curator)

LFNG was added to Congenital disorders of glycosylationpanel. Source: Literature Model of inheritance for gene LFNG was set to BIALLELIC, autosomal or pseudoautosomal

1 Dec 2016, Gel status: 1

Added New Source

Sarah Leigh (Genomics England Curator)

LFNG was added to Congenital disorders of glycosylationpanel. Sources: Emory Genetics Laboratory

1 Dec 2016, Gel status: 0

Created

Sarah Leigh (Genomics England Curator)

LFNG was created by sleigh